Red cell folate and plasma homocysteine in preterm infants

Neonatology

Volumn 92, Issue 4, 2007, Pages 264-268

  Jyothi, S ^a,c   Misra, I ^a   Morris, G ^a   Benton, A ^a   Griffin, D ^a   Allen, S ^b  

^a SINGLETON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WALES   (United Kingdom)

^c Derby Teaching Hospitals NHS FT   (United Kingdom)

Author keywords

Breast milk fortifiers; Cerebrovascular disease; Homocysteine; Preterm formula milks; Red cell folate

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ARTICLE; BREAST MILK; ERYTHROCYTE; FEMALE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL;

BRAIN DISEASES; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MILK, HUMAN; PREGNANCY;

EID: 36248996601     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000103745     Document Type: Article

References (20)

1. Aslinia F, Mazza JJ, Yale SH: Megaloblastic anemia and other causes of macrocytosis. Clin Med Res 2006;4:236-241.
2. Ek J: Plasma and red cell folate values in newborn infants and their mothers in relation to gestational age. J Pediatr 1977;96:288-292.
3. Ek J, Magnus E: Plasma and red cell folate in breastfed infants. Acta Paediatr Scand 1979;68:239-243.
4. Ek J, Behnecke L, Halvorsen K.S, Magnus E: Plasma and red cell folate values and folate requirements in formula-fed premature infants. Eur J Pediatr 1984;142:78-82.
5. Vanier TM, Tyas JF: Folic acid status in premature infants. Arch Dis Child 1967;42:57-61.
6. Tsang RC, Lucas A, Uauy R: Nutritional Needs of the Preterm Infant: Scientific Basis and Practical Guidelines. New York, Caduceus Medical, 1993, pp 56-65.
7. Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999;354:407-413.
8. McCully KS: Homocysteine and vascular disease. Nat Med 1996;2:386-389.
9. Hogeveen M, Bloom HJ, Amernogen MV, Boogmans B, Van Beynum IM, Ven De Bor, M: Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants. J Pediatr 2002;141:429-431.
10. Refsum H, Grindflek A, Ueland P, et al: Screening for serum total homocysteine in newborn children. Clin Chem 2004;50:1769-1784.
11. Honsprabhas P, Saboohi F, Aranda JV, Bardin CL, Kovacs LB, Papageorgiou AN, Hoffer LJ: tHcy concentrations in preterm infants. Biol Neonate 1999;76:65-71.
12. Volpe JJ: Brain injury in the premature infant: overview of clinical aspects, neuropathology and pathogenesis. Semin Pediatr Neurol 1998;5:135-151.
13. Arpino C, D'Argenzio L, Ticconi C, Di Paolo A, Stellin V, Lopez L, Curatolo P: Brain damage in preterm infants: etiological pathways. Ann Ist Super Sanita 2005;41:229-237.
14. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC: Homocysteine causes cerebrovascular leakage in mice. Am J Physiol 2006;290:H1206-H1213.
15. Aguilar B, Rojas JC, Collados MT: Metabolism of homocysteine and its relationship with cardiovascular disease. J Thromb Thrombolysis 2004;18:75-87.
16. Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
17. B-Vitamin Treatment Trialists' Collaboration: Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006;151:282-287.
18. Papoutsakis C, Yiannakouris N, Manios Y, Papaconstantinou E, Magkos F, Schulpis KH, Zampelas A, Matalas AL: The effect of MTHFR (C677T) genotype on tHcy concentrations in healthy children is influenced by gender. Eur J Clin Nut 2006;60:155-162.
19. Rook JL, Nugent DJ, Young G: Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations. J Pediatr Hematol Oncol 2005;27:590-593.
20. Wintrobee's Clinical Haematology, ed 10. Baltimore, Williams & Wilkins, 1999, vol 2, 2746t.